Systemic inflammation is increasingly recognized as a key contributor to acute heart failure (AHF) and is associated with adverse outcomes. However, its relationship with objective imaging markers of cardiac dysfunction and pulmonary congestion in AHF remains incompletely understood.
This study examined as...
Z. Juma, F. S. Davidovski, C. Espersen et al.· European Heart Journal· 0 citations
Background:
Adults with neurological or cerebrovascular (NeCVD) disease have an elevated risk of influenza-related complications. Whether HD-IIV provides greater relative benefit over SD-IIV in this population is uncertain.
Objective:
To evaluate the relative vaccine effectiveness (rVE) of high-dose inactivate...
M. Yafasov, N. Johansen, D. Modin et al.· Circulation· 0 citations
Individuals living with heart failure (HF) are predisposed to severe cardio-respiratory disease (CRD) complications following respiratory syncytial virus (RSV) infection. A bivalent RSV prefusion F protein-based (RSVpreF) vaccine reduced the risk of hospitalization for RSV-related respiratory tract disease (RTD),...
K. Skaarup, M. Lassen, M. Yafasov et al.· European Heart Journal· 0 citations
Myocarditis and pericarditis are inflammatory cardiac syndromes that have been monitored as outcomes of special interest in adult vaccination programs. Previous randomized and observational studies of RSVpreF vaccination have not identified an association with these events; however, given their low incidence, pri...
M. Yafasov, M. Pareek, M. Lassen et al.· European Heart Journal· 0 citations
A prespecified analysis of the complete two-season DAN-RSV trial cohort will examine the vaccine effectiveness (VE) of RSVpreF versus no vaccine on respiratory and CV events among participants with or without pre-existing ASCVD.
M. Pareek, M. Lassen, M. Yafasov et al.· European Heart Journal· 0 citations
Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with an increased risk of heart failure, particularly heart failure with preserved ejection fraction (HFpEF). The prevalence of HFpEF and related patient-reported functional limitations in MASLD patients with preserved left ventricular...
M. Ramadan, F. S. Davidovski, C. Espersen et al.· European Heart Journal· 0 citations
The clinical relevance of left atrial (LA) dysfunction in acute heart failure (AHF) is unclear. Whether LA strain reflects disease mechanisms and predicts adverse outcomes in this heterogeneous population remains insufficiently investigated.
The aim was to examine the relationships between LA reservoir str...
M. Pedersen, F. Davidovski, C. Espersen et al.· European Heart Journal· 0 citations
AIM
This trial investigated whether colchicine, an anti-inflammatory treatment, affects cardiovascular structure and function, assessed by arterial stiffness, blood pressure and biochemistry, compared with placebo.
METHODS
COHERENT was a randomized, double-blind, placebo-controlled trial of the effects of colchicine...
A. Langhoff, N. Johansen, K. Bartholdy et al.· European Journal of Preventi...· 0 citations
Hypertension is a common and important risk factor for cardiovascular (CV) disease. The immune system and inflammatory response contribute to the pathology of hypertension. Colchicine has shown promise in delaying the progression of manifest atherosclerotic disease. However, the effects of colchicine on cardiac s...
A. Langhoff, N. Johansen, K. Bartholdy et al.· European Heart Journal· 0 citations
BACKGROUND
Respiratory syncytial virus (RSV) is an important cause of severe respiratory disease in adults, with the highest burden among older adults and individuals with chronic health conditions. The bivalent RSV prefusion F (RSVpreF) vaccine has been shown to prevent RSV-associated respiratory illness, but data fro...
M. Lassen, S. Christensen, M. Yafasov et al.· NEJM Evidence· 1 citation
BACKGROUND
Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty...
C. Espersen, N. Johansen, D. Modin et al.· The Lancet Healthy Longevity· 0 citations
Abstract Introduction Sex differences in chronic heart failure are well established, but corresponding differences in acute heart failure (AHF), particularly in multimodal imaging findings and short-term recovery, remain incompletely characterized. Methods In this prospective observational study, 567 adults hospitalize...
A. Khoraizat, F. Davidovski, C. Espersen et al.· ESC Heart Failure· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.